BABAT TBの開発と評価: 結核の治療薬への従順性を高めるためのスマートシステムベースのリマインダーボックス
Sri Ratna Rahayu1, Anan Nugroho2, Dina Nur Anggraini Ningrum1
1Department of Public Health, Faculty of Medicine, Universitas Negeri Semarang, Semarang, Indonesia.
Healthcare informatics research
|February 13, 2026
まとめ
BABAT TB スマートメディケーションボックスプロトタイプは,結核 (TB) 患者さんが薬物レベルをモニタリングし,適時な薬剤リマインダーを提供することにより,治療に順守するのを助けます. このシステムは,より良い患者の治療結果とデータ追跡をサポートしています.
科学分野:
- バイオメディカルエンジニアリング
- 医療情報工学 医療情報工学
- 医療機器開発 医療機器の開発
背景:
- 結核 (TB) 治療の順守は,患者の成功のために非常に重要です.
- スマートな医薬品管理システムは,患者のコンプライアンスに関する課題に対処することができます.
- 既存のソリューションには,リアルタイムモニタリングとデータ伝送機能が欠けている可能性があります.
研究 の 目的:
- 結核の治療薬順守を改善するためのスマートシステムプロトタイプ"BABAT TB"の開発と評価.
- リアルタイムモニタリングとアラート機能を備えた機能的な医薬品ボックスを作成します.
- 結核患者の治療スケジュールをサポートするプロトタイプの能力を評価する.
主な方法:
- システム開発のためにデザイン科学研究方法論を利用した.
- 薬物量の統合モニタリングとリアルタイムリマインダー/アラームシステム.
- データの送信のためにSIMレジスタを介してシリアル通信を採用し,長寿命のリチウム電池で動いています.
主要な成果:
- 入力制御,タイマー,薬物量検回路を含むプロトタイプハードウェアを正常に組み立て,電源を供給しました.
- 設定されたタイマーとアラーム機能は,医学的処方箋と一致し,適切な医薬品の警告を確実にします.
- 薬物の量と薬剤スケジュールの遵守の効果的なリアルタイムモニタリングが実証されています.
結論:
- BABAT TBプロトタイプは,薬の量測定とタイムリーアラートを通じて,結核治療の遵守を効果的に改善します.
- このシステムは,薬物の量,診察スケジュール,患者IDのデータをデータベースに転送することを容易にする.
- このスマートシステムは,結核患者の管理と治療結果を改善する可能性を示している.
関連する概念動画
Self-Evaluation: Self-Enhancement and Self-Verification
5.8K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
Inhaled Medications
833
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
833
Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II
1.6K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.6K
Pulmonary Tuberculosis V
651
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
651
Pulmonary Tuberculosis III
1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.1K


